Description

Cyclo(RGDyK) trifluoroacetate is a potent and selective αVβ3 integrin inhibitor with an IC50 of 20 nM.–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–Cancer-programmed cell death–C31H43F6N9O12—Pharmaceuticals. 2021 Mar 14;14(3):260.|Stem Cell Res Ther. 2022 Jul 18;13(1):327.|Biochem Pharmacol. 2023 Sep 14;115808.-[1]Haubner R, et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001 Feb;42(2):326-36.–250612-42-1–847.72–99.92–O=C(N[C@H](C(N[C@H]1CCCNC(N)=N)=O)CCCCN)[C@H](NC([C@@H](NC(CNC1=O)=O)CC(O)=O)=O)CC2=CC=C(O)C=C2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F–Cancer–DMSO : 100 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)–Integrin–αvβ3–Cytoskeleton–Peptides